Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
Top Cited Papers
Open Access
- 17 March 2010
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 303 (11), 1070-1076
- https://doi.org/10.1001/jama.2010.261
Abstract
While anatomical resection is the standard treatment for early stage lung cancer, some patients cannot tolerate surgery due to comorbidities such as emphysema and heart disease. These patients are deemed medically inoperable and are generally offered conventional radiotherapy (most commonly given during 20-30 outpatient treatments) or observed without specific cancer therapy. Outcomes are not ideal with either approach. Conventional radiotherapy fails to durably control the primary lung tumor in 60% to 70% of patients.1-3 More than half of patients ultimately die specifically from progressive lung cancer with observation4,5 and 2-year survival is less than 40% with either approach.Keywords
This publication has 19 references indexed in Scilit:
- Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II StudyInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Dosimetric Evaluation of Heterogeneity Corrections for RTOG 0236: Stereotactic Body Radiotherapy of Inoperable Stage I-II Non–Small-Cell Lung CancerInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung CancerInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Stereotactic Body Radiation Therapy in Multiple Organ SitesJournal of Clinical Oncology, 2007
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung CancerJournal of Clinical Oncology, 2006
- Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancerActa Oncologica, 2006
- Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frameInternational Journal of Radiation Oncology*Biology*Physics, 2005
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Radiation therapy for medically inoperable stage I and II non-small cell lung cancerCancer Treatment Reviews, 1989